Nathan White, CPC

Nathan White, CPC

Director, Insights and Strategy (Pricing and Market Access) at BioVid Corporation

View articles by Nathan White, CPC

Navigating The Last Mile: Innovative Contracting Strategies for Gene Therapies

Navigating The Last Mile: Innovative…

December 5, 2024

15 likes1 comment

Weathering the Coming Storm: Impact of Medicare Maximum Fair Price on the Oral Oncology Landscape

Weathering the Coming Storm: Impact of…

November 7, 2024

4 likes

What you need to know about pre-approval information exchange: lessons learned

What you need to know about pre-approval…

September 2, 2022

6 likes

Looking back on 2020 and where do we go from here...

Looking back on 2020 and where do we go from…

January 7, 2021

8 likes

Trends in US Payer Decision Making: Resources, Processes, Timing, and Collaborations

Trends in US Payer Decision Making:…

November 16, 2020

1 like

Why understanding payer archetypes is key to US market access

Why understanding payer archetypes is key to…

June 25, 2020

17 likes

Interview: PRMA Consulting Expands Its US Presence

Interview: PRMA Consulting Expands Its US…

February 21, 2020

4 likes

Industry Perceptions and Expectations: The Role of ICER as an Independent HTA Organisation

Industry Perceptions and Expectations: The…

January 11, 2019

10 likes1 comment

What ICER Pricing Would Mean for US Drug Spend: A Preliminary Analysis

What ICER Pricing Would Mean for US Drug…

September 20, 2018

16 likes

Is ICER our Robin Hood? The Role of an Independent HTA in the Sherwood Forest of US Drug Pricing and Market Access

Is ICER our Robin Hood? The Role of an…

June 14, 2018

13 likes

The Rise of Value-Based Contracting for Biopharmaceuticals and Medical Technologies

The Rise of Value-Based Contracting for…

March 14, 2018

15 likes

What’s Next In US Payor Communications: The Impact of FDA’s Proposed Guidance on Communication of Healthcare Economic Information

What’s Next In US Payor Communications: The…

March 23, 2017

2 likes

Join our free information session on March 23rd as experts discuss new FDA guidance on communications with US payors.

Join our free information session on March…

March 8, 2017

Sr. Principal/Principal, Global Market Access and Medical Affairs

Sr. Principal/Principal, Global Market…

December 14, 2016

Enhancement and integration of real-world evidence planning, generation and communication in response to increasing demand for insight-driven evidence

Enhancement and integration of real-world…

November 2, 2016

9 likes

  翻译：